GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Price-to-Funds-From-Operations

Accelerated Pharma (Accelerated Pharma) Price-to-Funds-From-Operations : (As of May. 17, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Accelerated Pharma (Accelerated Pharma) Business Description

Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.